This report contains market size and forecasts of Cell-based Flu Vaccine in global, including the following market information:
Global Cell-based Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell-based Flu Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Cell-based Flu Vaccine companies in 2021 (%)
The global Cell-based Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell-based Flu Vaccine include GlaxoSmithKline, Sanofi, Pfizer, MedImmune, LLC, Intravacc, CSL Limited, E. Merck KG, Novartis and Danaher Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell-based Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell-based Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Cell-based Flu Vaccine Market Segment Percentages, by Type, 2021 (%)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Cell-based Flu Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Cell-based Flu Vaccine Market Segment Percentages, by Application, 2021 (%)
Aldults
Children
Global Cell-based Flu Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Cell-based Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell-based Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell-based Flu Vaccine revenues share in global market, 2021 (%)
Key companies Cell-based Flu Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Cell-based Flu Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Sanofi
Pfizer
MedImmune, LLC
Intravacc
CSL Limited
E. Merck KG
Novartis
Danaher Corporation
SINOVAC